Skip to content

Bausch Health Companies BHC Diversified — Additions

Other segment segments

Bausch + Lomb
$0-100%
International
$0
Salix
$0
Solta Medical
$0-100%

Similar metrics at other companies

Parker-Hannifin logo
PHDiversified Industrial — Property Additions
$80M+35.6%
DuPont de Nemours, Inc. logo
DDDiversified Industrials — Segment, Expenditure, Addition to Long-Lived Assets
$34M+54.5%
Parker-Hannifin logo
PHDiversified Industrial — Acquisition
$2M
DuPont de Nemours, Inc. logo
DDDiversified Industrials — Goodwill recognized for Acquisition
$0
DuPont de Nemours, Inc. logo
DDDiversified Industrials — Goodwill
$3.51B
Parker-Hannifin logo
PHDiversified Industrial — Goodwill
$8.15B+7.9%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.86B-15.9%

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's diversified — additions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's diversified — additions?
Bausch Health Companies (BHC) reported diversified — additions of $0 in Q1 2026.
What does diversified — additions mean?
Reflects the increase in the carrying amount of goodwill within the Diversified segment due to new business combinations or acquisitions. This metric tracks the capital deployed to expand the segment's product portfolio through external growth. It is a key indicator of the company's inorganic investment strategy within this specific business unit.